De Barra C, Khalil M, Mat A, ODonnell C, Shaamile F, Brennan K, et al
doi: 10.1016/j.antiviral.2018.11.007
Understanding these differences helps clinicians and patients make informed treatment decisions
Meanwhile, chitosan-loaded EOs at 150 g/mL completely degrade biofilm structure and formation in Acinetobacter baumannii and effectively eradicates it 153
For the millions of people in the UK living with conditions like Hashimotos thyroiditis or hypothyroidism, these medicationsoriginally developed for type 2 diabetescan be a significant tool for managing metabolic health
Source: New England Journal of Medicine - SELECT Trial Up to 50% improvement in sleep apnea Studies show significant reduction in apnea-hypopnea index (AHI) with GLP-1 therapy, improving sleep quality and reducing OSA severity